المؤلفون: Henry, Robert R, Müller-Wieland, Dirk, Taub, Pam R, Bujas-Bobanovic, Maja, Louie, Michael J, Letierce, Alexia, Ginsberg, Henry N

المصدر: Diabetes, obesity & metabolism. 20(7)

مصطلحات موضوعية: Humans, Lipoprotein(a), Apolipoproteins B, Antibodies, Monoclonal, Anticholesteremic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Drug Therapy, Combination, Double-Blind Method, Adult, Aged, Middle Aged, Female, Male, Dyslipidemias, Cholesterol, LDL, Cholesterol, HDL, Randomized Controlled Trials as Topic, Clinical Trials, Phase III as Topic, Antibodies, Monoclonal, Humanized, Ezetimibe, Proprotein Convertase 9, Metabolic Syndrome, cardiovascular disease, clinical trial, dyslipidaemia, lipid-lowering therapy, Antibodies, Monoclonal, Drug Therapy, Combination, Cholesterol, LDL, HDL, Clinical Trials, Phase III as Topic, Humanized, Endocrinology & Metabolism, Clinical Sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/2h94h8rz

المؤلفون: Freddy G. Eliaschewitz, Alberto J. Lorenzatti, Maria Laura Monsalvo, Junbo Ge, Andrew Hamer, Nan Wang, Yundai Chen, Juming Lu, Zuyi Yuan

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, China, Statin, dyslipidaemia, Drug-Related Side Effects and Adverse Reactions, medicine.drug_class, Endocrinology, Diabetes and Metabolism, Atorvastatin, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, law.invention, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Randomized controlled trial, law, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Humans, Aged, Dyslipidemias, business.industry, hyperlipidaemia, Anticholesteremic Agents, nutritional and metabolic diseases, Original Articles, Middle Aged, medicine.disease, Clinical trial, Evolocumab, evolocumab, Diabetes Mellitus, Type 2, phase 3, lipids (amino acids, peptides, and proteins), Original Article, Female, type 2 diabetes, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115d25316fa518e8dbded86e41b96a58
http://europepmc.org/articles/PMC6594089

المؤلفون: Maria Laura Monsalvo, Andrew Hamer, Nan Wang, Alexis Baass, Yundai Chen, Junbo Ge, Alberto J. Lorenzatti, Freddy G. Eliaschewitz, Juming Lu

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Statin, dyslipidaemia, medicine.drug_class, Endocrinology, Diabetes and Metabolism, Atorvastatin, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Internal medicine, Internal Medicine, medicine, Humans, Adverse effect, Aged, Dyslipidemias, Aged, 80 and over, business.industry, hyperlipidaemia, Anticholesteremic Agents, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Original Articles, Middle Aged, medicine.disease, Evolocumab, Cholesterol, evolocumab, Diabetes Mellitus, Type 2, phase 3, lipids (amino acids, peptides, and proteins), Original Article, Female, type 2 diabetes, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, medicine.drug, Lipoprotein

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703c362aa62aef1dd291131ef0cc7900
http://europepmc.org/articles/PMC6594020